Skip to main content
. Author manuscript; available in PMC: 2012 Sep 19.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 Oct 28;68(2):379–388. doi: 10.1007/s00280-010-1481-z

Fig. 3.

Fig. 3

Deoxynucleotide cytidine triphosphate pools (dCTP) in peripheral blood mononuclear cells (PBMCs) before and 24-h post-treatment with 3-AP plus gemcitabine in patients 30 and 31. dCTP pool assays were performed in triplicate and repeated 3 times. There was a significant decrease after 3-AP/gemcitabine therapy in PBMC dCTP pools in patient 30 (P = 0.012), whereas a significant increase was seen in patient 31 (P = 0.044)